Anthony Walker Presenting at Adoptive T-Cell Therapy Congress, London

Anthony Walker PhD, FRSB, Managing Partner, will attend the Adoptive T-Cell Therapy Congress in London, UK on March 15-16th.

Anthony combines his background in management consulting with 12 years of experience as the CEO of Onyvax, an immune oncology company he founded in 1997.

Anthony will give a presentation at the Congress titled Commercialization of Adoptive T-Cells: Prospects and Hurdles.

The Adoptive T-Cell Therapy Congress will cover a wide variety of topics including safety concerns in T-cell therapy, chimeric antigen receptors, and TCRs in immunotherapy.

 

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Stay in touch